Furthermore, studies have shown that NLRP3 activation has been implicated in an inflammasome complex which involves triggering the NF-κB pathway with release of IL-1β all of which may play a significant role in CaNL and eventually in the development of chronic kidney disease [28]. Here, NFKB1 is linked to chronic kidney disease.